Healthcare & Life Sciences

Exin Therapeutics

United States

seed

Stage

Investors

About

Exin Therapeutics uses AI models trained on high-density multimodal mouse data combined with in-house high-throughput mouse studies to discover therapeutics that modulate neural activity, initially targeting epilepsies associated with autism and Parkinson’s disease.

Explore Exin Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.